Population Genomics

Our Partnerships

The Global Standard

We developed our platform in Iceland to meet the unprecedented challenge of storing and efficiently mining population-scale sequence data. Today it remains the only platform proven and used at this scale and is the choice of institutions & organizations the world over focused on advancing precision medicine at scale.

Genomics England

Genomics England

Genomics England has selected WuXi NextCODE as the only Clinical Interpretation Partner working across the breadth of the 100,000 Genomes Project. WuXi NextCODE is the first to work with them on cancer samples and will also interpret samples in rare disease. Genomics England is working with WuXi NextCODE to drive up the quality of interpretation of genomic data. This will lead to better understanding of disease and more personalised care for patients in the future.

More
Sidra

Sidra Medical and Research Center

Sidra Medical and Research Center is the genomics and informatics hub for the Qatar Genome Project, the first nationwide precision medicine effort in the world. Sidra has selected WuXi NextCODE as its long-term partner for delivering pathbreaking genome-based medicine and research to benefit the citizens of Qatar and patients throughout the region and the world. WuXi NextCODE has installed the full breadth of its infrastructure for large-scale research and clinical genomics at Sidra and is working closely with them to co-develop comprehensive research and bioinformatics programs.

More




SFARI

Simons Foundation Autism Research

The Simons Simplex Collection, assembled by the Simons Foundation Autism Research Initiative (SFARI), is the world's largest collection of genomic data in autism and one of the largest single phenotype datasets created to date.

More
San Antonio 1000 Cancer Genome Project

San Antonio 1000 Cancer Genome Project

San Antonio's 1000 Cancer Genome Project (START) is the first longitudinal study of tumor-normal whole genome data. It uses the WuXi NextCODE system to match the whole genome data in real time with patient progress and outcomes. The results are made freely available worldwide.

More